HPR and cholangiocarcinoma: Knocking down or genetically depleting HPR increases the phosphorylation of Raptor at Ser792, which is repressed in the presence of exogenous HPR. Knockdown or knockout of HPR in breast cancer and cholangiocarcinoma cells leads to a reduction in tumour growth.